Mcnulty Korea Co., Ltd. agreed to acquire Mayjun Biotech Co., Ltd. from Mayjun Life & Health Co., Ltd. for KRW 4.2 billion.
June 14, 2021
Share
Mcnulty Korea Co., Ltd. (KOSDAQ:A222980) agreed to acquire Mayjun Biotech Co., Ltd. from Mayjun Life & Health Co., Ltd. for KRW 4.2 billion on June 15, 2021. Mcnulty Korea Co., Ltd. will acquire 0.2 million shares of Mayjun Biotech Co., Ltd. for a consideration to be paid in cash. Mayjun Biotech Co., Ltd. reported sales of KRW 12 billion, total assets of KRW 8.046 billion, total debt of KRW 6.84 billion, total equity of KRW 1.206 billion and Net loss of KRW 200 million. The transaction is expected to close on July 1, 2021. As per correction on July 1, 2021, the transaction is expected to close on July 9, 2021.
Mcnulty Korea Co., Ltd. is a Korea-based company mainly engaged in the manufacture of coffees. The Company purchases green beans of coffee and produces coffees of different types by roasting. The Company's product portfolio consists of roasted coffees including whole beans, crushed beans, triangular tea bags, square tea bags and hand drips, instant coffees including coffee mixes and instant bean coffees and coffee beverages including portion coffees and ice coffees. The Company also manufactures ethical (ETC) drugs including painkillers, diabetes diagnosis drugs and colonic irrigation drugs and over the counter (OTC) drugs including cold medicines, hair restorers and cold medicines for children.
MCNULTY KOREA CO., LTD. 
